EDTUTC-4 New YorkLog in Sign up

MDCO
Medicines Co
stockNASDAQ

InactiveJan 3, 2020 4:00:00 PM EST

84.90USD-0.071%(-0.06)

MDCO News

Day breaks

07:15 AM EDTINmune Bio Advances Ebstrocel™ Toward Potential UK Approval in Mid-2027 ·

GlobeNewswire Inc.

07:00 AM EDTSlate Medicines Strengthens Board of Directors with Appointment of Stephen K. Brannan, MD, and John D. Young ·

GlobeNewswire Inc.

08:28 AM EDTFutures Rise As Warsh Stays Mum, Tesla "Flying Car" Interrupts AI Liquidation ·

Zero Hedge

07:36 AM EDTCHMP Backs Ionis TRYNGOLZA For Severe Hypertriglyceridemia In Europe ·

RTTNews

06:45 AM EDTSobi receives positive CHMP opinion for TRYNGOLZA® (olezarsen) for the treatment of severe hypertriglyceridemia (sHTG) ·

Cision

03:34 PM EDTThese 2 Stocks Have Run Circles Around the Magnificent Seven This Year, and Wall Street Says There Is More Upside Ahead ·

The Motley Fool

01:28 PM EDTRevolution Medicines' Pancreatic Cancer Drug Gets Positive EU Review ·

RTTNews

09:45 AM EDTRevolution Medicines’ RASONQUE™ (daraxonrasib) Receives Positive CHMP Opinion Recommending Marketing Authorization in European Union for Metastatic Pancreatic Cancer ·

GlobeNewswire Inc.

09:30 AM EDTGilead and Vir forge $1.9bn pact to develop next-gen T-cell engagers ·

Pharmaceutical Technology

08:47 AM EDTFedEx digitizes booking process for European cold-chain pharma shipments ·

FreightWaves

06:55 AM EDTZydus Plans a USD 20 Million Drug Plant in Sri Lanka, With Output Expected in 2028 ·

Trade Brains

06:30 AM EDTQuoin Pharmaceuticals Announces European Medicines Agency (EMA) Grants Orphan Drug Designation for QRX003 for the Treatment of Peeling Skin Syndrome ·

GlobeNewswire Inc.

04:30 AM EDTAlvotech and Advanz Pharma announce first known regulatory submission worldwide for proposed biosimilar to Eylea® 8 mg ·

GlobeNewswire Inc.

04:30 AM EDTAlvotech and Advanz Pharma announce first known regulatory submission worldwide for proposed biosimilar to Eylea® 8 mg ·

GlobeNewswire Inc.

10:00 AM EDTPrologue Medicines Appoints Stephen Harrison, Ph.D., as Chief Scientific Officer ·

PR Newswire

08:30 AM EDTWave Life Sciences to Present at Chardan’s 10th Annual Healthcare Conference ·

GlobeNewswire Inc.

08:00 AM EDTNImmune Biopharma Presented New Data at ACG 2026 Supporting the Efficacy and Safety of Innovative LANCL2 Medicines Targeting a Novel Mechanism in Hard-to-Treat IBD ·

Business Wire

02:00 AM EDTHow can runaway spending in the health service be reined in? ·

The Irish Times

01:56 AM EDTTwo Former Moderna Cancer Vaccine Scientists Join Everest Medicines, Accelerating Global Development of Its mRNA Platform ·

ACN Newswire

10:15 PM EDTEverest Medicines Appoints Two Veteran mRNA Cancer Vaccine Scientists to Advance Global Clinical Development ·

PR Newswire